Bristol-Myers Squibb Company vs キーエンス
時価総額の推移比較
Bristol-Myers Squibb Company
$125.6B
順位 #132
キーエンス
$127.4B
順位 #130
時価総額の推移
主な転換点
- キーエンスが2021年までにBristol-Myers Squibb Companyを上回った
- Bristol-Myers Squibb Companyが2022年までにキーエンスを上回った
- キーエンスが2023年までにBristol-Myers Squibb Companyを上回った
- Bristol-Myers Squibb Companyが2024年までにキーエンスを上回った
- キーエンスが2026年までにBristol-Myers Squibb Companyを上回った
年次比較
| 年 | Bristol-Myers Squibb Company | キーエンス | 首位 |
|---|---|---|---|
| 2026 | $125.6B | $127.4B | キーエンス |
| 2025 | $107.8B | $91.7B | Bristol-Myers Squibb Company |
| 2024 | $107.6B | $103.7B | Bristol-Myers Squibb Company |
| 2023 | $92.9B | $99.2B | キーエンス |
| 2022 | $125.8B | $81.7B | Bristol-Myers Squibb Company |
| 2021 | $105.8B | $114.3B | キーエンス |
| 2020 | $102.0B | $91.4B | Bristol-Myers Squibb Company |
| 2019 | $102.4B | $60.3B | Bristol-Myers Squibb Company |
| 2018 | $80.2B | $43.5B | Bristol-Myers Squibb Company |
| 2017 | $92.0B | $49.2B | Bristol-Myers Squibb Company |
| 2016 | $85.4B | $31.2B | Bristol-Myers Squibb Company |
| 2015 | $98.2B | $26.0B | Bristol-Myers Squibb Company |
| 2014 | $82.3B | $20.8B | Bristol-Myers Squibb Company |
| 2013 | $72.0B | $17.4B | Bristol-Myers Squibb Company |
| 2012 | $42.7B | $9.2B | Bristol-Myers Squibb Company |
| 2011 | $44.4B | $6.5B | Bristol-Myers Squibb Company |
| 2010 | $31.8B | $8.2B | Bristol-Myers Squibb Company |
| 2009 | $28.9B | $6.7B | Bristol-Myers Squibb Company |
| 2008 | $25.1B | $5.2B | Bristol-Myers Squibb Company |
| 2007 | $27.1B | $7.9B | Bristol-Myers Squibb Company |
| 2006 | $25.9B | $9.2B | Bristol-Myers Squibb Company |
| 2005 | $21.6B | $9.5B | Bristol-Myers Squibb Company |
| 2004 | $23.0B | $5.4B | Bristol-Myers Squibb Company |
| 2003 | $24.5B | $5.3B | Bristol-Myers Squibb Company |
| 2002 | $19.0B | $4.8B | Bristol-Myers Squibb Company |
| 2001 | $40.3B | $5.1B | Bristol-Myers Squibb Company |